All

Results: 42505-42516 of 43220

PR Newswire associated0

Multiplier Named No. 1 Most Implementable Employer of Record and Leader in G2's Fall Report

PR Newswire associated0

Stability AI launches Stable Audio, the Company's First Product to Generate Music Using Artificial Intelligence

Annual Investment Meeting announces new identity as AIM Congress, gears up for 13th edition in Abu Dhabi, May 2024

PR Newswire associated0

Medac GmbH Advances Pharmacovigilance Technology for Safety Monitoring of its Drugs with ArisGlobal Solutions

WorldRemit Data: 2023 Global Cost of Living Index Shows Significant Increases Since 2022

PR Newswire associated0

J1 Beach in Dubai to Launch Elevated Dining District Featuring 13 Luxury Beachfront Fine Dining and Club Experiences

Closing the Safety Gap: WATCHIT's Smart System Steps Up with New Standards in Recreational Boating Safety following Recent Tragedies

PR Newswire associated0

MoEngage Named A Leader in IDC MarketScape: Worldwide Omni-Channel Marketing Platforms for B2C Enterprises 2023

SMALL BUSINESSES ARE OWED £27K IN LATE PAYMENTS ON AVERAGE, ACCORDING TO INTUIT RESEARCH

Mackmyra creates whisky history with Sweden's first 20-year-old single malt

PR Newswire associated0

2D Fighting Game MELTY BLOOD: TYPE LUMINA Participate in PlayStation® BIG GAME BIG DEALS

Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China